The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Jan. 31, 2019
Applicant:
Horizon Orphan Llc, Lake Forest, IL (US);
Inventors:
Jeffery S. Loutit, Los Altos, CA (US);
Elizabeth E. Morgan, Escondido, CA (US);
Michael N. Dudley, San Diego, CA (US);
David C. Griffith, San Marcos, CA (US);
Olga Lomovskaya, Mountain View, CA (US);
Assignee:
Horizon Orphan LLC, Lake Forest, IL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5383 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 33/06 (2006.01); A61K 33/14 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5383 (2013.01); A61K 9/0078 (2013.01); A61K 9/08 (2013.01); A61K 33/06 (2013.01); A61K 33/14 (2013.01); A61K 45/06 (2013.01); Y02A 50/401 (2018.01); Y02A 50/469 (2018.01); Y02A 50/47 (2018.01); Y02A 50/471 (2018.01); Y02A 50/473 (2018.01); Y02A 50/475 (2018.01); Y02A 50/478 (2018.01); Y02A 50/481 (2018.01); Y02A 50/483 (2018.01);
Abstract
Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising